OmniAb Inc offers best-in-class therapeutic antibody discovery technologies. OmniAb Inc offers best-in-class therapeutic antibody discovery technologies.
APAC Shareholder Approval Obtained, Closing Scheduled for November 1, 2022 Ligand “Regular Way” and “Ex-Distribution” and OmniAb “When-Issued” Set to Begin Trading on October 25, 2022 Ligand...
Avista Public Acquisition Corp. II Announces Effectiveness of Registration Statement and Sets Date for Extraordinary General Meeting to Vote on Proposed Business Combination PR Newswire NEW YORK...
First European Commission approval of a bispecific antibody discovered using OmniAb OmniAb, Inc. is eligible to receive a $10 million milestone upon first commercial sale in Europe Ligand...
Raises 2022 Financial Guidance Conference Call Begins at 4:30 p.m. Eastern Time Today Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and six...
Conference Call Begins at 4:30 p.m. Eastern Time Today Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three months ended March 31, 2022 and provided...
Transaction will result in OmniAb becoming an independent publicly traded company Ligand’s shareholders to receive 100% of Ligand’s shares in OmniAb through a tax-free distribution immediately...
NEW YORK, Oct. 30, 2018 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading was halted today in Avista Healthcare Public Acquisition Corp. (Nasdaq: AHPA, AHPAU...
Avista Healthcare Public Acquisition Corp. To Combine With Organogenesis Inc. PR Newswire NEW YORK and CANTON, Mass., Aug. 17, 2018 NEW YORK and CANTON, Mass., Aug. 17, 2018 /PRNewswire/...
EAST MILLSTONE, N.J., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Envigo, a leading provider of nonclinical contract research services and research models, today announced the appointment of Lynn...
EAST MILLSTONE, N.J., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Envigo, a leading provider of non-clinical contract research services and research models, today announced it has allocated a $300...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.